Elite Pharmaceuticals Inc (ELTP)

[Thomas517]

Yes. I'm familiar with the clinical trials that showed promising data for treating Parkinson's with Isradipine and the current Phase 3 I believe trial is going with 336 patients, 56 sites across the U.S. and they are suppose to have data in March of 2019. We will see what happens with this. I don’t see any pharmaceutical companies not driven by specific pharmaceutical company; I believe its university and Michael J. Fox’s foundation. We are watching that very closely and we’ll see what the results are in March of next year. Frankly, regardless of the business, I hope it’s successful for the sake of people with Parkinson’s because it’s a horrible disease and we need to treat it and this is a treatment whether Elite benefits or not. That will be a wonderful thing for our society.